X-linked lymphoproliferative disease

X-linked lymphoproliferative disease (XLP), also known as Duncan's disease or Purtilo syndrome, is a rare genetic disorder characterized by an inappropriate immune response to the Epstein-Barr virus (EBV). This condition primarily affects males and can lead to severe immunological complications.

Causes

XLP is caused by mutations in specific genes located on the X chromosome:

• XLP1: Resulting from mutations in the SH2D1A gene, which encodes the SLAM-associated protein (SAP). Deficiencies in SAP impair the function of T and natural killer (NK) cells, leading to uncontrolled immune responses upon EBV infection.

• XLP2: Caused by mutations in the *XIAP* gene, leading to defects in apoptosis regulation and immune system dysfunction. :contentReference[oaicite:1]{index=1}

Symptoms

Individuals with XLP may exhibit:

• Fulminant Infectious Mononucleosis (FIM): An exaggerated response to EBV infection, leading to severe illness.
• Hemophagocytic Lymphohistiocytosis (HLH): A life-threatening condition characterized by excessive immune activation and tissue damage.
• Dysgammaglobulinemia: Abnormal levels of immunoglobulins, resulting in increased susceptibility to infections.
• Lymphomas: Increased risk of developing cancers of the lymphatic system. :contentReference[oaicite:2]{index=2}

Diagnosis

Diagnostic approaches include:

• Genetic testing: Identifying mutations in the SH2D1A or XIAP genes.
• Immunological assessments: Evaluating immune cell function and immunoglobulin levels.
• Family History analysis: Considering the X-linked inheritance pattern to assess risk in male relatives.

Treatment

Management strategies encompass:

• Hematopoietic stem cell transplantation (HSCT): The only curative treatment, replacing defective immune cells with healthy donor cells.
• Immunoglobulin replacement therapy: Administering immunoglobulins to prevent infections.
• Targeted therapies: Utilizing medications to modulate immune responses and control symptoms. :contentReference[oaicite:4]{index=4}

Prognosis

Without treatment, XLP often leads to severe complications and reduced life expectancy. Early diagnosis and appropriate interventions, such as HSCT, can significantly improve outcomes.

References

• MedlinePlus: X-linked lymphoproliferative disease
• GeneReviews: X-linked lymphoproliferative disease

External links

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia